| 000 | 02025nas a22002895i 4500 | ||
|---|---|---|---|
| 001 | 1534-6269 | ||
| 003 | DE-He213 | ||
| 005 | 20200203193251.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150723s||||||||xxuuu poo|||||| b|EN |d | ||
| 022 | _a1534-6269 | ||
| 024 | 7 |
_a10.1007/11912.1534-6269 _2doi |
|
| 210 | 1 | 0 | _aCurr Oncol Rep |
| 245 | 1 | 0 |
_aCurrent Oncology Reports _h[electronic resource] / _cedited by Maurie Markman. |
| 264 | 1 |
_aNew York : _bSpringer US : _bImprint: Springer. |
|
| 300 | _bonline resource. | ||
| 520 | _aThis journal aims to review the most important, recently published clinical findings in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided. | ||
| 650 | 0 | _aOncology. | |
| 650 | 1 | 4 |
_aOncology. _0http://scigraph.springernature.com/things/product-market-codes/H33160 |
| 700 | 1 |
_aMarkman, Maurie. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 776 | 0 | 8 |
_iPrinted version: _x1523-3790 |
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/11912.1534-6269 _zHybrid |
| 999 |
_c455722 _d455722 |
||
| 942 | _cEMG | ||